Why is Dr Agarwals Eye Hospital Ltd falling/rising?

Recent Price Performance and Market Context

The stock has demonstrated impressive momentum over the past week, appreciating by 5.33%, in stark contrast to the Sensex which declined by 2.33% during the same period. Over the last month, Dr Agarwals Eye Hospital Ltd has outpaced the benchmark with a 5.35% gain compared to the Sensex’s 3.50%. Despite a year-to-date decline of 5.84%, the stock’s resilience is evident when viewed against the broader market’s 10.04% fall. Over the longer term, the company’s shares have delivered exceptional returns, surging by 14.86% in the past year and an extraordinary 332.70% over three years, far surpassing the Sensex’s 27.65% gain in that timeframe.

On the day in question, the stock outperformed its sector by 4.14%, reaching an intraday high of ₹5,138.05, a 5.38% increase from the previous close. Notably, the stock has been on a two-day winning streak, accumulating a 4% return in this short span. The trading activity reveals a higher volume near the lower price range of the day, suggesting some profit-taking, yet the overall trend remains firmly bullish. Crucially, the share price is trading above all major moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling strong technical support and positive investor sentiment.

Investor participation has surged significantly, with delivery volumes on 23 Apr rising by an extraordinary 740.87% compared to the five-day average. This heightened liquidity, with the stock capable of handling trade sizes of approximately ₹0.02 crore based on recent averages, further underscores robust market interest and confidence.

Fundamental Strength Driving the Rally

The stock’s rise is underpinned by the company’s strong financial fundamentals. Dr Agarwals Eye Hospital Ltd has reported positive results for four consecutive quarters, signalling consistent operational efficiency and profitability. The company’s profit after tax (PAT) for the nine-month period stands at ₹53.86 crore, reflecting a robust growth rate of 39.32%. Operating profit to interest ratio has reached a peak of 16.93 times, indicating strong earnings relative to debt servicing costs. Additionally, profit before tax excluding other income has surged by 76.00% to ₹20.68 crore, highlighting core business strength.

Long-term growth metrics further reinforce the stock’s appeal. Operating profit has expanded at an impressive annualised rate of 83.03%, demonstrating the company’s ability to scale its operations effectively. Return on capital employed (ROCE) is a healthy 16.6%, suggesting efficient utilisation of capital to generate earnings. The enterprise value to capital employed ratio stands at a reasonable 4.8, indicating fair valuation levels relative to the company’s asset base.

Despite these strong fundamentals, the stock is trading at a discount compared to its peers’ historical valuations, offering an attractive entry point for investors. The price-to-earnings-growth (PEG) ratio of 1.1 aligns with the company’s profit growth of 35.8% over the past year, signalling a balanced valuation relative to earnings expansion.

Consistent returns over the last three years have further cemented investor confidence. The stock has outperformed the BSE500 index in each of the past three annual periods, delivering compounded gains that far exceed broader market benchmarks.

Conclusion: A Stock Supported by Growth and Market Confidence

The recent rise in Dr Agarwals Eye Hospital Ltd’s share price on 24-Apr is a reflection of its strong quarterly earnings, sustained long-term growth, and favourable valuation metrics. The stock’s outperformance relative to the Sensex and its sector peers, combined with increased investor participation and technical strength, suggests a positive market outlook. While the year-to-date performance shows a modest decline, the company’s consistent profitability and operational efficiency provide a solid foundation for future gains. Investors looking for exposure to a healthcare services company with demonstrated growth and reasonable valuation may find Dr Agarwals Eye Hospital Ltd an attractive proposition in the current market environment.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →